Concepedia

Esther Bulle

EB

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2015

Affiliations

University of Amsterdam(Current)

Amsterdam University Medical Centers

Amsterdam Neuroscience

Amsterdam UMC Location University of Amsterdam

Vrije Universiteit Amsterdam

Esther Bulle is an author at University of Amsterdam specializing in covid-19, medicine, and clinical trials.

ORCID

Top concepts

Publications per year

2015–2023

8

Publications

8

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Bernadette Schurink, Eva Roos, Teodora Radonic et al. · The Lancet Microbe · 2020 · 554 citations · Full text

, , +8

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch et al. · The Lancet Rheumatology · 2020 · 198 citations · Full text

, , +7

Clinical features and prognostic factors in Covid-19: A prospective cohort study

Sanne de Bruin, Lieuwe D. J. Bos, Marian A. van Roon et al. · EBioMedicine · 2021 · 135 citations · Full text

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19

Erik H Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen et al. · The Journal of Immunology · 2020 · 79 citations · Full text

Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells

Ruud Weijer, Mans Broekgaarden, Rowan F. van Golen et al. · BMC Cancer · 2015 · 40 citations · Full text

1–5 of 8